X
Please Wait
Applying Filters...
01 NOVARTIS (3)
01 TABLET, FOR SUSPENSION;ORAL (3)
01 RX (3)
01 EXJADE (3)
01 Yes (3)
19
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DEFERASIROX, with a corresponding application number 21882.
Regulatory Information RX
With a dosage strength 500MG
Dosage Form Route TABLET, FOR SUSPENSION; ORAL
Reference Listed Drug Yes
Approved since 2005-11-02
Therapeutic Equivalence (TE) Code AB
18
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DEFERASIROX, with a corresponding application number 21882.
Regulatory Information RX
With a dosage strength 125MG
Dosage Form Route TABLET, FOR SUSPENSION; ORAL
Reference Listed Drug Yes
Approved since 2005-11-02
Therapeutic Equivalence (TE) Code AB
17
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DEFERASIROX, with a corresponding application number 21882.
Regulatory Information RX
With a dosage strength 250MG
Dosage Form Route TABLET, FOR SUSPENSION; ORAL
Reference Listed Drug Yes
Approved since 2005-11-02
Therapeutic Equivalence (TE) Code AB
Market Place
